-
公开(公告)号:US20240010724A1
公开(公告)日:2024-01-11
申请号:US17933277
申请日:2022-09-19
Applicant: AMGEN INC. , AMGEN RESEARCH (MUNICH) GMBH
Inventor: Shouhua Xiao , Zheng Pan , Dineli Wickramasinghe , M. Shawn Jeffries , Chadwick Terence King , Brian Mingtung Chan , Peter Kufer , Ralf Lutterbüse , Tobias Raum , Patrick Hoffmann , Doris Rau , Roman Kischel , Bryan Lemon , Holger Wesche
CPC classification number: C07K16/2809 , C07K16/28 , C07K16/3053 , A61K2039/505 , C07K16/2896 , C07K16/468 , A61K47/60
Abstract: The present invention provides to a antibody construct comprising a first human binding domain capable of binding to human CDH19 on the surface of a target cell and a second domain capable of binding to human CD3 on the surface of a T cell. Moreover, the invention relates to a nucleic acid sequence encoding the antibody construct, a vector comprising said nucleic acid sequence and a host cell transformed or transfected with said vector. Furthermore, the invention relates a process for the production of the antibody construct of the invention, a medical use of said antibody construct and a kit comprising said antibody construct.
-
公开(公告)号:US11498964B2
公开(公告)日:2022-11-15
申请号:US16040927
申请日:2018-07-20
Applicant: AMGEN RESEARCH (MUNICH) GMBH , AMGEN INC.
Inventor: Shouhua Xiao , Zheng Pan , Dineli Wickramasinghe , M. Shawn Jeffries , Chadwick Terence King , Brian Mingtung Chan , Peter Kufer , Ralf Lutterbüse , Tobias Raum , Patrick Hoffmann , Doris Rau , Roman Kischel , Bryan Lemon , Holger Wesche
Abstract: The invention provides a bispecific antibody construct comprising a first human binding domain capable of binding to human CDH19 on the surface of a target cell and a second domain capable of binding to human CD3 on the surface of a T cell. Moreover, the invention provides a nucleic acid encoding the antibody construct, a vector comprising the nucleic acid and a host cell transformed or transfected with the vector. Furthermore, the invention provides a process for the production of the bispecific antibody construct, a medical use of the antibody construct and a kit comprising the antibody construct. The bispecific antibody construct may be useful in the treatment of melanoma.
-
公开(公告)号:US10059766B2
公开(公告)日:2018-08-28
申请号:US14761839
申请日:2014-01-27
Applicant: AMGEN RESEARCH (MUNICH) GMBH , AMGEN INC.
Inventor: Shouhua Xiao , Zheng Pan , Dineli Wickramasinghe , M. Shawn Jeffries , Chadwick Terence King , Brian Mingtung Chan , Peter Kufer , Ralf Lutterbüse , Tobias Raum , Patrick Hoffmann , Doris Rau , Roman Kischel , Bryan Lemon , Holger Wesche
Abstract: The invention provides a bispecific antibody construct comprising a first human binding domain capable of binding to human CDH19 on the surface of a target cell and a second domain capable of binding to human CD3 on the surface of a T cell. Moreover, the invention provides a nucleic acid encoding the antibody construct, a vector comprising the nucleic acid and a host cell transformed or transfected with the vector. Furthermore, the invention provides a process for the production of the bispecific antibody construct, a medical use of the antibody construct and a kit comprising the antibody construct. The bispecific antibody construct may be useful in the treatment of melanoma.
-
公开(公告)号:US09765157B2
公开(公告)日:2017-09-19
申请号:US14815861
申请日:2015-07-31
Applicant: AMGEN INC. , AMGEN RESEARCH (MUNICH) GMBH
Inventor: Shouhua Xiao , Zheng Pan , Dineli Wickramasinghe , Peter Kufer , Patrick Hoffmann , Tobias Raum , Ralf Lutterbüse , Elisabeth Nahrwold , Claudia Blumel
CPC classification number: C07K16/468 , A61K47/60 , A61K2039/505 , C07K16/28 , C07K16/2809 , C07K16/2896 , C07K16/30 , C07K2317/21 , C07K2317/30 , C07K2317/31 , C07K2317/33 , C07K2317/622 , C07K2317/73 , C07K2319/00
Abstract: The present invention provides a bispecific antibody construct comprising a first human binding domain which binds to human CDH19 on the surface of a target cell and a second binding domain which binds a human CD3 on the surface of a T cell. Moreover, the invention provides a polynucleotide encoding the antibody construct, a vector comprising the polynucleotide and a host cell transformed or transfected with the polynucleotide or vector. Furthermore, the invention provides a process for the production of the antibody construct of the invention, a medical use of the antibody construct in the treatment of melanoma, and a kit comprising the antibody construct.
-
公开(公告)号:US12297292B2
公开(公告)日:2025-05-13
申请号:US15673539
申请日:2017-08-10
Applicant: AMGEN INC. , AMGEN RESEARCH (MUNICH) GMBH
Inventor: Shouhua Xiao , Zheng Pan , Dineli Wickramasinghe , Peter Kufer , Patrick Hoffmann , Tobias Raum , Ralf Lutterbüse , Elisabeth Nahrwold , Claudia Blumel
Abstract: A bispecific antibody construct comprising a first human binding domain which binds to human CDH19 on the surface of a target cell and a second binding domain which binds to human CD3 on the surface of a T cell. A nucleic acid comprising a polynucleotide encoding the antibody construct, a vector comprising the nucleic acid comprising the polynucleotide and a host cell transformed or transfected with the nucleic acid comprising the polynucleotide or vector. A process for the production of the antibody construct, a medical use of the antibody construct in the treatment of melanoma, and a kit comprising the antibody construct.
-
公开(公告)号:US20220127354A1
公开(公告)日:2022-04-28
申请号:US17326717
申请日:2021-05-21
Applicant: AMGEN INC.
Inventor: Shouhua Xiao , Zheng Pan , Dineli Wickramasinghe , M. Shawn Jeffries , Chadwick Terence King , Brian Mingtung Chan
Abstract: The present disclosure provides a human antibody or antigen binding fragment thereof or an antibody construct comprising a human binding domain or antigen binding fragment thereof capable of binding to human CDH19 on the surface of a target cell. The disclosure relates to a nucleic acid sequence encoding the antibody or antigen binding fragment thereof contained in the antibody construct, a vector comprising the nucleic acid sequence and a host cell transformed or transfected with the vector. Furthermore, the disclosure relates to a process for the production of the antibody construct of the disclosure, a medical use or a method of treatment using the antibody construct and a kit comprising the antibody or antigen binding fragment thereof or the antibody construct.
-
公开(公告)号:US11053311B2
公开(公告)日:2021-07-06
申请号:US15878047
申请日:2018-01-23
Applicant: AMGEN INC.
Inventor: Shouhua Xiao , Zheng Pan , Dineli Wickramasinghe , M. Shawn Jeffries , Chadwick Terence King , Brian Mingtung Chan
Abstract: The present disclosure provides a human antibody or antigen binding fragment thereof or an antibody construct comprising a human binding domain or antigen binding fragment thereof capable of binding to human CDH19 on the surface of a target cell. The disclosure relates to a nucleic acid sequence encoding the antibody or antigen binding fragment thereof contained in the antibody construct, a vector comprising the nucleic acid sequence and a host cell transformed or transfected with the vector. Furthermore, the disclosure relates to a process for the production of the antibody construct of the disclosure, a medical use or a method of treatment using the antibody construct and a kit comprising the antibody or antigen binding fragment thereof or the antibody construct.
-
公开(公告)号:US09920121B2
公开(公告)日:2018-03-20
申请号:US14762053
申请日:2014-01-27
Applicant: AMGEN INC.
Inventor: Shouhua Xiao , Zheng Pan , Dineli Wickramasinghe , M. Shawn Jeffries , Chadwick Terence King , Brian Mingtung Chan
IPC: A61K39/395 , C07K16/28 , C07K16/30 , A61K47/68 , A61K39/00
CPC classification number: C07K16/28 , A61K47/6803 , A61K47/6849 , A61K47/6865 , A61K2039/505 , C07K16/3053 , C07K2317/21 , C07K2317/33 , C07K2317/34 , C07K2317/55 , C07K2317/73 , C07K2317/77 , C07K2317/92
Abstract: The present disclosure provides a human antibody or antigen binding fragment thereof or an antibody construct comprising a human binding domain or antigen binding fragment thereof capable of binding to human CDH19 on the surface of a target cell. The disclosure relates to a nucleic acid sequence encoding the antibody or antigen binding fragment thereof contained in the antibody construct, a vector comprising the nucleic acid sequence and a host cell transformed or transfected with the vector. Furthermore, the disclosure relates to a process for the production of the antibody construct of the disclosure, a medical use or a method of treatment using the antibody construct and a kit comprising the antibody or antigen binding fragment thereof or the antibody construct.
-
公开(公告)号:US20150322151A1
公开(公告)日:2015-11-12
申请号:US14762053
申请日:2014-01-27
Applicant: AMGEN INC.
Inventor: Shouhua Xiao , Zheng Pan , Dineli Wickramasinghe , M. Shawn Jeffries , Chadwick Terence King , Brian Mingtung Chan
CPC classification number: C07K16/28 , A61K47/6803 , A61K47/6849 , A61K47/6865 , A61K2039/505 , C07K16/3053 , C07K2317/21 , C07K2317/33 , C07K2317/34 , C07K2317/55 , C07K2317/73 , C07K2317/77 , C07K2317/92
Abstract: The present disclosure provides a human antibody or antigen binding fragment thereof or an antibody construct comprising a human binding domain or antigen binding fragment thereof capable of binding to human CDH19 on the surface of a target cell. The disclosure relates to a nucleic acid sequence encoding the antibody or antigen binding fragment thereof contained in the antibody construct, a vector comprising the nucleic acid sequence and a host cell transformed or transfected with the vector. Furthermore, the disclosure relates to a process for the production of the antibody construct of the disclosure, a medical use or a method of treatment using the antibody construct and a kit comprising the antibody or antigen binding fragment thereof or the antibody construct.
Abstract translation: 本公开提供了人抗体或其抗原结合片段或包含能够结合目标细胞表面上的人CDH19的人结合结构域或其抗原结合片段的抗体构建体。 本公开涉及编码抗体构建体中包含的抗体或其抗原结合片段的核酸序列,包含核酸序列的载体和用该载体转化或转染的宿主细胞。 此外,本公开涉及制备本公开的抗体构建体的方法,医疗用途或使用抗体构建体的治疗方法和包含抗体或其抗原结合片段或抗体构建体的试剂盒。
-
公开(公告)号:US20250084160A1
公开(公告)日:2025-03-13
申请号:US18610640
申请日:2024-03-20
Applicant: Amgen Inc.
Inventor: Shouhua Xiao , Zheng Pan , Dineli Wickramasinghe , M. Shawn Jeffries , Chadwick Terence King , Brian Mingtung Chan
Abstract: The present disclosure provides a human antibody or antigen binding fragment thereof or an antibody construct comprising a human binding domain or antigen binding fragment thereof capable of binding to human CDH19 on the surface of a target cell. The disclosure relates to a nucleic acid sequence encoding the antibody or antigen binding fragment thereof contained in the antibody construct, a vector comprising the nucleic acid sequence and a host cell transformed or transfected with the vector. Furthermore, the disclosure relates to a process for the production of the antibody construct of the disclosure, a medical use or a method of treatment using the antibody construct and a kit comprising the antibody or antigen binding fragment thereof or the antibody construct.
-
-
-
-
-
-
-
-
-